- Home
- KYMR vs IVT Comparison
KYMR vs IVT Comparison
Compare KYMR & IVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- IVT
- Stock Information
- Founded
- KYMR 2015
- IVT 2005
- Country
- KYMR United States
- IVT United States
- Employees
- KYMR N/A
- IVT N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- IVT Real Estate Investment Trusts
- Sector
- KYMR Health Care
- IVT Real Estate
- Exchange
- KYMR Nasdaq
- IVT Nasdaq
- Market Cap
- KYMR 2.6B
- IVT 2.2B
- IPO Year
- KYMR 2020
- IVT N/A
- Fundamental
- Price
- KYMR $40.61
- IVT $28.98
- Analyst Decision
- KYMR Buy
- IVT Buy
- Analyst Count
- KYMR 15
- IVT 4
- Target Price
- KYMR $55.60
- IVT $31.75
- AVG Volume (30 Days)
- KYMR 532.1K
- IVT 499.2K
- Earning Date
- KYMR 02-20-2025
- IVT 02-11-2025
- Dividend Yield
- KYMR N/A
- IVT 3.13%
- EPS Growth
- KYMR N/A
- IVT 189.28
- EPS
- KYMR N/A
- IVT 0.10
- Revenue
- KYMR $87,563,000.00
- IVT $294,559,000.00
- Revenue This Year
- KYMR N/A
- IVT N/A
- Revenue Next Year
- KYMR $33.16
- IVT $10.57
- P/E Ratio
- KYMR N/A
- IVT $291.75
- Revenue Growth
- KYMR 86.92
- IVT 13.58
- 52 Week Low
- KYMR $26.92
- IVT $23.53
- 52 Week High
- KYMR $53.27
- IVT $31.65
- Technical
- Relative Strength Index (RSI)
- KYMR 47.90
- IVT 40.22
- Support Level
- KYMR $40.20
- IVT $27.78
- Resistance Level
- KYMR $44.34
- IVT $29.69
- Average True Range (ATR)
- KYMR 2.58
- IVT 0.65
- MACD
- KYMR 0.29
- IVT -0.04
- Stochastic Oscillator
- KYMR 57.47
- IVT 44.12
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.
About IVT InvenTrust Properties Corp.
InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.